Ewa Czarnobilska

Ewa Czarnobilska

Auto-generated profile, based on publicly available information

Ewa Czarnobilska

Department of Clinical and Environmental Allergology, Medical College, Jagiellonian University, Botaniczna 3, Kraków, 31-503, Poland

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 March 2021 in Environmental Science and Pollution Research
Verified
Journal Article
Open access
PDF file
MZMonika Ziemianin
Monika Ziemianin
JWJacek Waga
Jacek Waga
ECEwa Czarnobilska
Ewa Czarnobilska
DMDorota Myszkowska
Dorota Myszkowska
Birch (Betula pendula) pollen causes inhalant allergy in about 20% of human population in Europe, most of which is sensitive to the main birch allergen, Bet v1. The aim of the study was to find out (i) whether and how the analysed birch individuals differ in regard to composition of individual subunits of pollen proteins and to protein content in these subunits; (ii) whether the level of particulate matter relates to concentration of Bet v1 allergen. Study was performed in Southern Poland, in 2017–2019. Pollen material was collected at 20 sites, of highly or less polluted areas. Protein composition was analysed by SDS-PAGE, while the concentration of Bet v1 was evaluated by ELISA. The obtained results were estimated at the background of the particulate matter (PM10) level and the birch pollen seasons in Kraków. The electrophoregrams of pollen samples collected at different sites showed huge differences in staining intensities of individual protein subunits, also among important birch allergens: Bet v1, Bet v2, Bet v6 and Bet v7. The level of Bet v1 was significantly higher in the pollen samples collected at the more polluted sites. While the birch pollen allergenic potential is determined, the both pollen exposure and the content of the main allergenic components should be considered, as factors causing immunological response and clinical symptoms manifestation in sensitive individuals.

13 February 2026 in Scientific Reports
Verified
Journal Article
Open access
DMDorota Myszkowska
Dorota Myszkowska
AKAgnieszka Kubik-Komar
Agnieszka Kubik-Komar
KPKatarzyna Piotrowicz
Katarzyna Piotrowicz
KDKatarzyna Dąbrowska-Zapart
Katarzyna Dąbrowska-Zapart
ŁGŁukasz Grewling
Łukasz Grewling
ECEwa Czarnobilska
Ewa Czarnobilska
The online version contains supplementary material available at 10.1038/s41598-026-36159-0.

30 November 2021 in Alergoprofil
Verified
Journal Article
Open access
PDF file
WSWeronika Sułkowska
Weronika Sułkowska
ECEwa Czarnobilska
Ewa Czarnobilska
Alergia na jad owadów błonkoskrzydłych to najczęstsza przyczyna wstrząsu anafilaktycznego u dorosłych, a druga po alergii pokarmowej u dzieci. W warunkach polskich najczęstszymi przyczynami alergii są użądlenia przez pszczoły miodne (Apis mellifera), osy (Vespula spp.) oraz szerszenie (Vespa spp., częściej u osób już wcześniej żądlonych przez osy). Skutkiem użądlenia jest zazwyczaj odczyn miejscowy, jednak ok. 3% dorosłych i 0,5% dzieci reaguje odczynami ogólnoustrojowymi o charakterze anafilaksji. Diagnostyka nadwrażliwości na jady bywa trudna, szczególnie gdy wywiad nie wskazuje jednoznacznie na owada sprawczego. Jej podstawą są testy skórne z jadem osy i pszczoły: punktowe (prick test) i śródskórne o łącznej czułości 94%, i oznaczenie poziomu specyficznych IgE, których czułość wynosi od 83% do 100%. Postawą leczenia jest immunoterapia swoista, do której są kwalifikowani pacjenci z ciężkimi reakcjami anafilaktycznymi i udowodnionym mechanizmem IgE-zależnym alergii. W wyjątkowych sytuacjach do leczenia są kwalifikowane osoby z dużymi odczynami miejscowymi narażone na częste użądlenia z racji wykonywanej pracy oraz z izolowanymi zmianami skórnymi, które znacznie obniżają jakość ich życia. Immunoterapia swoista jest jedyną skuteczną metodą leczenia, trwa 3–5 lat, a jej skuteczność wynosi 91–96% przy alergii na jad osy oraz 77–84% przy alergii na jad pszczoły.

1 December 2021
Verified
Book
Closed access
ABAndrzej Bant
Andrzej Bant
ZBZbigniew Bartuzi
Zbigniew Bartuzi
MBMarcin Baut
Marcin Baut
ŁBŁukasz Błażowski
Łukasz Błażowski
ABAnna Bodzenta-Łukaszyk
Anna Bodzenta-Łukaszyk
ZSZbigniew Samochocki
Zbigniew Samochocki

30 November 2016 in Polish Archives of Internal Medicine
Verified
Journal Article
Open access
MLMałgorzata Leśniak
Małgorzata Leśniak
MMMarcel Mazur
Marcel Mazur
ECEwa Czarnobilska
Ewa Czarnobilska

11 August 2026 in Allergy
Verified
Journal Article
Open access
MCMaria Czarnobilska
Maria Czarnobilska
MBMałgorzata Bulanda
Małgorzata Bulanda
ECEwa Czarnobilska
Ewa Czarnobilska
WDWojciech Dyga
Wojciech Dyga
Marek JutelMarek Jutel
Marek Jutel
DMDorota Myszkowska
Dorota Myszkowska
Background: Sensitization to birch pollen is a major contributor to allergic rhinitis in Europe, with sensitization rates in many countries from 10% to 20% of the general population. Growing evidence suggests that air pollution enhances the allergenicity of pollen; however, the clinical consequences of this co‐exposure remain poorly understood. This study investigated whether air pollution intensifies birch pollen allergenicity and assessed its effects on symptom severity and basophil activation in allergic and non‐allergic individuals. Methods: Fifty birch‐allergic patients and twenty‐five non‐atopic controls were examined over two consecutive pollen seasons (2023–2024). Daily nasal, ocular, and asthma symptoms were recorded using a mobile application. Ambient air pollutants (PM 2.5 , PM 10 , and O 3 ) and birch pollen concentrations were continuously monitored in Kraków. Basophil activation tests (BAT) were performed using commercial birch pollen extracts, Bet v1 allergen, and natural pollen collected from highly and less polluted areas. Basophil activation was quantified by CD63 expression using flow cytometry. Results: Asthmatic symptoms showed significant positive correlations with both birch pollen and PM concentrations ( p < 0.05), especially in 2023. Pollen collected from polluted sites induced significantly stronger basophil activation compared with pollen from less polluted areas ( p < 0.0001). The magnitude of basophil activation correlated with serum IgE levels to birch and Bet v 1, as well as with clinical symptom scores. Conclusions: Air pollution enhances the allergenic potency of birch pollen, resulting in heightened basophil activation and more severe allergic symptoms. These findings highlight the importance of integrating air pollution monitoring alongside pollen surveillance when assessing allergic disease burden and evaluating the effectiveness of allergen immunotherapy.